Radiomics is a promising methodology that automatically extracts high-dimensional features from imaging data for supplementary evaluation of prognosis. Herein, we developed radiomic signature based on pretreatment MRI, which can be used as a biomarker for risk stratification for disease-free survival (DFS) in patients with early-stage cervical cancer. This study provides a non-invasive and cost-effective preoperative predictive tool to identify the early stage cervical cancer patients with high possibility of recurrence or metastasis; and they may help to determine whether more intensive observation and aggressive treatment regimens should be administered, aim at assisting clinical treatment and healthcare decisions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords